How Unlearn Builds Trustworthy AI From Messy Clinical Data

By Unlearn

Oct 8 • 

Unlearn

2

Driving Clinical Trial Innovation with our Partners: Q3 at Unlearn

By Steve Herne, CEO of Unlearn

Oct 7 • 

Unlearn

September 2025

Empowering Biostatistics Teams with AI That Works for Them

By Unlearn

Sep 24 • 

Unlearn

August 2025

How Unlearn Embeds into Clinical Trial Teams

By Unlearn

Aug 12 • 

Unlearn

What’s Next in AD Research? Highlights and Lessons from AAIC 2025

By Unlearn

Aug 7 • 

Unlearn

July 2025

Real Trials, Real Impact: Q2 at Unlearn

By Steve Herne, CEO of Unlearn

Jul 10 • 

Unlearn

June 2025

The Best 15 Minutes You’ll Spend on Clinical Trials Today

By Unlearn

Jun 25 • 

Unlearn

How Unlearn Boosts Trial Power Using the FDA’s AI Framework

By Aaron Smith, Co-Founder and Machine Learning Scientist

Jun 24 • 

Unlearn

1

May 2025

How we’re helping biotechs like ProJenX run smarter ALS trials

By Steve Herne, CEO of Unlearn

May 16 • 

Unlearn

April 2025

Unlocking Smarter Parkinson’s Disease Trials with Digital Twins

Clinical research in Parkinson’s disease (PD) is often slowed by long timelines, noisy outcomes, and the need for large patient cohorts.

Apr 30 • 

Unlearn

February 2025

Smarter Endpoints, Stronger Trials: How AI-Optimized Measures Are Advancing Neurodegenerative Disease Research

By Unlearn

Feb 13 • 

Unlearn

January 2025

Why the FDA’s New AI Guidelines Matter for Clinical Research

By Steve Herne, CEO of Unlearn

Jan 9 • 

Unlearn

4